Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current NI H Clinical Center operation details and references for status checks.SummaryDifference3%

- Check34 days agoChange Detected- Updated software version to v3.1.0 and added contact details (phone numbers and email). - Removed the old version reference v3.0.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element was removed.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms related to hypereosinophilic syndrome and hemic and lymphatic diseases. However, several previous terms and conditions related to chronic graft versus host disease and ruxolitinib phosphate have been removed.SummaryDifference3%

- Check77 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.